Biogen Pharmachem Industries Ltd Share Price

Finance - Investment / Others

BSE: 531752 Small Cap ISIN: INE703D01023

As on 27 December 2024 at 05:46 IST

₹1.19

+ 0.02

(1.71%)

Buy Sell

Over 1 Month

-4.03%

Over 6 Months

7.21%

Over 1 Year

-18.49%

Over 3 Years

124.53%

Overview News Financials Corporate Actions

Biogen Pharmachem Industries Ltd Summary

Close 1.19

Open 1.20

High 1.20

Low 1.18

Volume 11,74,383

Net Turnover (in ₹) 13,96,902

52 Week High 1.79

52 Week Low 0.98

52Wk High / Low

0.98

1.79

Biogen Pharmachem Industries Ltd Key Financial Data

Market Cap (in ₹ Cr) 77.66

EPS (TTM) -

Book Value (BV) 0.85

Div. Yield -

P/E (TTM) -119

Price/Book Value 1.40

Delivery % 54.96

Face Value 1

Biogen Pharmachem Industries Ltd Key Ratios

P/E ratio 35.33

P/B ratio 1.22

EV to Sales 87.54

PEG Ratio 0.18

ROA 3.41

ROE 0.52

Debt-Equity -

Net Profit Margin 14.29

Operating Profit Margin 15.13

Biogen Pharmachem Industries Ltd Peer Comparison

Company	LTP	Market Cap (in ₹ Cr)
Biogen Pharmachem Industries Ltd	₹1.19	₹77.66
Bajaj Finance Ltd	₹6,816.70	₹4,21,951.32
Bajaj Finserv Ltd	₹1,559.80	₹2,49,047.35
Jio Financial Services Ltd	₹305.40	₹1,94,029.30
Indian Railway Finance Corporation Ltd	₹146.80	₹1,91,845.67
Power Finance Corporation Ltd	₹463.05	₹1,52,811.21

Biogen Pharmachem Industries Ltd News

Biogen Pharmachem Industries to announce Quarterly Result

On 13 November 2024

17 Oct 2024

Biogen Pharmachem Industries to convene AGM

On 28 September 2024

16 Sep 2024

Biogen Pharmachem Industries to hold AGM

On 28 September 2024

14 Sep 2024

Biogen Pharmachem Industries revises board meeting date

To 13 August 2024

10 Aug 2024

Biogen Pharmachem Industries to conduct board meeting

On 9 August 2024

02 Aug 2024

Biogen Pharmachem Industries Ltd Financials

Standalone

Consolidated

Profit and Loss

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	2.38	0.91	2.48	1.62	-
Total Expenses	0.45	0.46	2.49	3.23	0.12
Profit Before Tax	1.93	0.46	-0.01	-1.60	-0.12
Profit After Tax	1.93	0.46	-0.01	-1.60	-0.12
Operating Profit after Depreciation	1.93	0.46	-0.01	-1.60	-0.12

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	-	-	-	-	-
Total Non Current Assets	56.73	54.67	53.02	51.69	48.05
Total Current Assets	0.09	0.15	1.93	2.56	8.04
TOTAL ASSETS	56.82	54.83	54.95	54.25	56.09
Total Shareholder's Fund	56.52	54.59	54.13	54.14	55.75

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	1.94	1.70	1.40	3.95	-1.21
Net Cash used in Investing Activities	-2.06	-1.66	-1.32	-3.64	1.54
Net Cash used in Financing Activities	-	-	-	-0.31	-0.32

Biogen Pharmachem Industries Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 27 Sep 2022

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of Annual General Meeting of the company to be held on 27.09.2022 This is for your information and records. Thanking you, Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Wednesday, September 21, 2022 to Tuesday, September 27, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of Annual General Meeting of the Company to be held on September 27, 2022. You are requested to take note of the above and bring this to the notice of all concerned. Thanking you, In terms of Regulation 30 read with Part A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the following businesses were transacted at the 27th Annual General Meeting of the Company held on Tuesday the 27th September 2022 at 11:00 A.M. through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). 1. Ordinary Resolution for adoption of the audited financial statements of the Company for the Financial Year ended 31st March 2022 and Reports of the Directors and Auditors thereon. 2. Special Resolution for appointment of MR. NIRAJ VAGHELA (DIN NO.: 09096576) as Wholetime Director and Chief Financial Officer of the Company. 3. Ordinary Resolution for Appointment of Mr. CHANDRAKANT GOVINDBHAI PARMAR (DIN: 09406801) as an Independent Director of the Company. 4. Ordinary Resolution for Appointment of Ms. MANJULABEN PARMAR (DIN: 09420512), as an Independent Director of the Company. (As Per BSE Announcement dated on 27.09.2022) Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the voting results of the business transacted at the Annual General Meeting of the Company held on Tuesday the 27th September 2022 at 11:00 A.M through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM').in the prescribed format. Kindly take note of the above. Thanking you. (As per BSE Announcement Dated on 28/9/2022)

AGM Date: 30 Sep 2023

AGM 30/09/2023 PFA (As per BSE Announcement Dated on 30/09/2023)

AGM Date: 28 Sep 2024

AGM 28/09/2024 PFA (As Per BSE Announcement Dated on 28.09.2024)

Biogen Pharmachem Industries Ltd Stock Analysis

Annual revenue for Biogen Pharmachem Industries Ltd increased by 160.90% to ₹2.38 crore in FY 2024 from ₹0.91 crore in FY 2023.
Annual Net Profit for Biogen Pharmachem Industries Ltd increased by 323.86% to ₹1.93 crore in FY 2024 from ₹0.46 crore in FY 2023.
Promoter Shareholding in Biogen Pharmachem Industries Ltd remains unchanged by 0.00% in the most recent quarter, from 0% in June 2024 to 0% in September 2024.
Biogen Pharmachem Industries Ltd delivered a 1-year return of -18.49% compared to the Nifty 50, which provided a return of 0% as of the last trading session.
Biogen Pharmachem Industries Ltd share price moved up by 1.71% from its previous close of INR ₹1.17. The latest Biogen Pharmachem Industries Ltd share price is INR ₹1.19.
Biogen Pharmachem Industries Ltd share price today has been at a low of 1.18 and a high of 1.20. Over the past 52 weeks, the Biogen Pharmachem Industries Ltd share price has seen a low of 0.98 and a high of 1.79.

FAQ’s

What is the share price of Biogen Pharmachem Industries Ltd today?

Biogen Pharmachem Industries Ltd share price as on 27 Dec 2024 is ₹ 1.19

What is the Market Cap of Biogen Pharmachem Industries Ltd?

The market cap of Biogen Pharmachem Industries Ltd stock is ₹77.66 Cr.

What is the PE Ratio of Biogen Pharmachem Industries Ltd?

The Price to Earnings (P/E) Ratio of Biogen Pharmachem Industries Ltd is 35.33

What is the PB Ratio of Biogen Pharmachem Industries Ltd?

The Price to Book (P/B) Ratio of Biogen Pharmachem Industries Ltd is 1.22

What is the 52 week high of Biogen Pharmachem Industries Ltd Share Price?

The 52 week high of Biogen Pharmachem Industries Ltd share price stands at ₹1.79

What is the 52 week low of Biogen Pharmachem Industries Ltd Share Price?

The 52 week low of Biogen Pharmachem Industries Ltd share price stands at ₹0.98

Open Free
Demat Account!

Enjoy ₹11 Brokerage on Stocks Delivery

Equity, F&O and
DP Charges